Condition: Risk of Breast Cancer · Risk of Gynaecological Cancer · Risk of Colorectal Cancer · Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
LEAH is a prospective, observational, single-centre, non-randomised, open-label study of people at increased risk of cancer or malignant disease. The main objective of LEAH is to evaluate and compare the sensitivity of different tests on body fluids to detect cancers that will occur within 3 years of inclusion in the study, in a cohort of individuals identified as being at increased risk of cancer.
This description comes directly from the study's public registry record.
Suzette Delaloge, MD · +33 (0)1 42 11 42 11 · suzette.delaloge@gustaveroussy.fr
Adeline Salasc, PharmD · +33 (0)1 42 11 42 11 · adeline.salasc@gustaveroussy.fr
Always discuss trial participation with your own doctor first.
| Gustave Roussy | Villejuif, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06907095